Title:
ヒト免疫不全ウイルス複製の阻害剤
Document Type and Number:
Japanese Patent JP7361766
Kind Code:
B2
Abstract:
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
Inventors:
Iaugu, Christiana
Parsera, Kyle E.
Peace, Kevin M
Parsera, Kyle E.
Peace, Kevin M
Application Number:
JP2021514019A
Publication Date:
October 16, 2023
Filing Date:
September 12, 2019
Export Citation:
Assignee:
Veeve Healthcare UK (Number 5) Limited
International Classes:
C07D471/04; A61K31/496; A61K31/4985; A61K31/506; A61K31/519; A61K31/5365; A61K45/00; A61P31/18; A61P43/00
Domestic Patent References:
| JP7307747B2 | ||||
| JP7301000B2 | ||||
| JP2021534102A | ||||
| JP2017525722A | ||||
| JP2016510038A | ||||
| JP2016504392A |
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office